LEESBURG, Va., Sept. 2, 2014 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market MESA Hooks, the latest implant addition to the MESA® Deformity Spinal System. K2M also received the CE Mark for MESA Hooks, which allows the Company to expand the global presence of this complex spine line extension.
The MESA Hook extension to the existing MESA Deformity Spinal System provides a unique low-profile option to this versatile system. The MESA Deformity System, designed for use in complex spine surgeries, contains a wide range of implants and instruments for the treatment of deformity, trauma and tumor. K2M's low-profile, top-loading MESA Technology features Zero-Torque Technology®, which offers surgeons the ability to one-step lock without torsional stress applied to the spine. The MESA Hooks line extension includes a variety of transverse process hooks, laminar hooks and pedicle hooks.
According to Hilali Noordeen, MA, BM BCh (Oxon), FRCS (Eng), MCh Orth., FRCS (Orth), a Consultant Spinal Surgeon at the Royal National Orthopaedic Hospital in the United Kingdom: "The MESA Hooks offer surgeons flexibility to complete an entire MESA construct. They allow for the use of Crickets® at every level, and they work well with MESA Rail™."
In addition to MESA Hooks, the MESA Deformity Spinal System is comprised of MESA Foundation Screws, MESA Deformity Uniplanar Screws, MESA 360° Screws, Cobalt Chrome and Titanium Rods, and MESA Rails. The revolutionary design of the Reduction Jacks (Crickets), coupled with a complete offering of varied screw and hook types, provide surgeons with the ability to accomplish the most difficult correction maneuvers across all planes utilizing unique instrumentation for slow, controlled correction of the spine.
"We are pleased to receive 510(k) clearance and the CE Mark for MESA Hooks, which will enhance our portfolio and support our effort to expand our global penetration of the complex spine market with the MESA Spinal Deformity System. The unique low-profile MESA Hooks in combination with differentiated technology such as the MESA Rail provide surgeons with a wide range of fixation option for patients with severe spinal deformities," stated Eric Major, K2M's President and CEO. "These regulatory milestones are further examples of our commitment to innovation and achieving the highest level of excellence in the development of technologies to support surgeons treating the most complex spinal pathologies."
For more information on K2M's product portfolio, visit www.K2M.com.
About K2M
K2M Group Holdings, Inc. is a global medical device company focused on designing, developing and commercializing innovative complex spine and minimally invasive spine technologies and techniques used by spine surgeons to treat some of the most difficult and challenging spinal pathologies. K2M has leveraged these core competencies to bring to market an increasing number of products for patients suffering from degenerative spinal conditions. These technologies and techniques, in combination with a robust product pipeline, enable the Company to favorably compete in the global spinal surgery market. Additional information is available online at www.K2M.com.
Forward-Looking Statements
Certain statements made in this press release may constitute "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements are based on management's expectations, estimates, projections, and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. Additional information regarding these factors is contained in the Company's Registration Statement on Form S-1 filed with the SEC.
Find K2M on Facebook: https://www.facebook.com/K2MInc
Follow K2M on Twitter: http://twitter.com/K2MInc
Watch K2M on YouTube: http://www.youtube.com/user/K2MInc